Optimize patient stratification to accelerate oncology clinical development

Through access to very large and homogenous patient cohorts over the last 10 years we have developed AI algorithms predicting cancer therapy response rates. Using this we can accelerate clinical development timelines and lower the failure rate. We aim to at least halve the failure of oncology clinical development whilst significantly increasing the number of accelerated approvals.